{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16"],"submitter":["Shitaye G"],"pubmed_abstract":["Long COVID, or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), refers to a range of persistent health effects associated with SARS-CoV-2 infection. Long COVID is a complex, multisystem disorder that can affect nearly every organ system and is strongly linked with the incidence of diabetes and other chronic conditions. Increasing evidence also connects persistent SARS-CoV-2 infection with the development of new-onset diabetes and other metabolic disorders. In this review, we assess the current evidence and discuss the incidence of new-onset diabetes, along with the pathobiological mechanisms by which SARS-CoV-2 may contribute to the progression of both new-onset type 1 and type 2 diabetes mellitus (T1DM and T2DM). We summarize the latest"],"journal":["Frontiers in endocrinology"],"pagination":["1737894"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12756089"],"repository":["biostudies-literature"],"pubmed_title":["Molecular analysis of long COVID and new-onset diabetes mellitus: pathobiological relationships and current mechanistic views."],"pmcid":["PMC12756089"],"pubmed_authors":["D'Abrosca G","Fattorusso R","Mekonnen Z","Isernia C","Getie M","Amuamuta A","Shitaye G","Malgieri G"],"additional_accession":[]},"is_claimable":false,"name":"Molecular analysis of long COVID and new-onset diabetes mellitus: pathobiological relationships and current mechanistic views.","description":"Long COVID, or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), refers to a range of persistent health effects associated with SARS-CoV-2 infection. Long COVID is a complex, multisystem disorder that can affect nearly every organ system and is strongly linked with the incidence of diabetes and other chronic conditions. Increasing evidence also connects persistent SARS-CoV-2 infection with the development of new-onset diabetes and other metabolic disorders. In this review, we assess the current evidence and discuss the incidence of new-onset diabetes, along with the pathobiological mechanisms by which SARS-CoV-2 may contribute to the progression of both new-onset type 1 and type 2 diabetes mellitus (T1DM and T2DM). We summarize the latest","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-06-06T11:15:11.699Z","creation":"2026-05-29T03:12:28.887Z"},"accession":"S-EPMC12756089","cross_references":{"pubmed":["41488148"],"doi":["10.3389/fendo.2025.1737894"]}}